Moderna to Trial HIV and Flu Vaccines With mRNA

3 years ago
8

Moderna to Trial HIV and Flu Vaccines With mRNA Technology
The astonishing success of COVID-19 vaccines may signal a breakthrough in disease prevention technology.

Moderna is developing influenza and HIV vaccines using mRNA technology, the backbone of its effective COVID-19 vaccine. The biotech company is expected to launch phase 1 trials for its mRNA flu and HIV vaccines this year. If successful, mRNA may offer a silver lining to the decades-long fight against HIV, influenza, and other autoimmune diseases.

Loading comments...